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Gliotoxin Mediated Apoptotic Cell Death in Jurkat cells
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Introduction: In the immunocompromised host invasive aspergillo-
sis (IA) is an increasing problem with high mortality despite new
and improved antifungals. The mycotoxin gliotoxin is secreted dur-
ing hyphal growth of Aspergillus fumigatus. The toxin is detected in
the serum of patients with proven IA. Gliotoxin is immunosuppres-
sive and mediates proliferation, apoptosis and necrosis of different
cell-types. Its exact role in the pathogenesis of IA is still debated.
Objectives: We wanted to further investigate the effect of
gliotoxin on T-cells by studying death responses in the T cell line
Jurkat E6 induced by this toxin.
Methods: Jurkat E6 cells were incubated with or without 50-
2000ng/ml gliotoxin for 1 to 24 hours. Apoptotic cells death was
determined using Annexin-V-FLUOS and propidium iodide (PI) stain-
ing. Analysis of active caspase 3, -8 and -9 were performed using
selective antibodies, loss of mitochondrial membrane potential by
JC-1 staining, and ROS production using hydroethidine staining af-
ter incubation with gliotoxin 250ng/ml for 4 hours. All assessments
were performed by flow cytometry. Staurosporine (1µM for 2 hours)
was used as positive control.
Results: We observed time- and concentration dependent cell
death in response to gliotoxin. Annexin V Fluos and PI staining sug-
gested apoptotic cell death with a maximal response after 4 to
6 hours of incubation with 500ng/ml gliotoxin. Furthermore, cell
death was almost completely blocked by the pan-caspase inhibitor
Z-VAD-FMK (100µM). After 4 hour incubation with gliotoxin, we
found caspase-3 activation (27-48% positive cells), caspase-9 ac-
tivation (21-54% positive cells) and cells with loss of mitochondrial
membrane potential (49-78%) suggesting apoptosis and mitochon-
drial involvement. We also found activation of caspase-8 (20-52%
positive cells) suggesting an involvement of death receptor path-
way as well. ROS generation was detected in less than 10% of the
cells after treatment.
Conclusions: Our data show a caspase dependent apoptotic cell
death of Jurkat T cells in presence of gliotoxin. This T cell apopto-
sis may contribute to reduced immunity to the fungus.
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Background: E. coli is the most frequent etiologic agent of urinary
tract infection (UTI). There are limited data comparing the preva-
lence of virulence factors in UPEC isolates from immunocompetent
and immunocompromised hosts.
Objectives: To compare the prevalence of virulence factors and
antimicrobial resistance in UPEC strains isolated from immunocom-
promised and immunocompetent subjects.
Materials and Methods: UPEC isolates were characterized ac-
cording to serotype, hemolytic and hemagglutination properties,
virulence determinant genes (pap1/pap2, sfa1/sfa2, afa1/afa2
hly1/hly2, aer1/aer2,cnf1/cnf2) and antimicrobial susceptibility.
Clinical presentation and patients' characteristics were abstracted
from charts.
Results: UPEC isolates from 36 immunocompromised patients (26
renal and 1 liver transplant recipients, 1 AIDS patient and other
8 subjects receiving immunossupressive therapy) and 27 immuno-
competent subjects with UTI were studied. Secondary bacteremia
occurred only in immunocompromised hosts (7 cases, p=0.02). Re-
sistance to quinolones tended to be less frequent among these pa-
tients (OR1.70; 95% IC=0.91-3.14, p=0.096). There was no signif-
icant difference between groups in the prevalence of resistance
to other antimicrobial drugs. There was no significant difference
between groups in the distribution of O-H serotypes, mannose re-
sistant or sensitive hemagglutination, and virulence determinant
genes. Quinolone resistance was associated with a lower preva-
lence of alfa-hemolysis (p=0.01), O serotypes classically associated
with pyelonephritis (p=0.017), and sfa1/sfa2 gene (p=0.003).
Conclusions: Despite the higher frequency of secondary bac-
teremia among immunocompromised patients there was no signifi-
cant difference in the prevalence of virulence factors in UPEC iso-
lates from these patients as compared with isolates from immuno-
competent controls. Quinolone resistance was associated with a
lower prevalence of virulence factors.
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Background: Strongyloidiasis has worldwide distribution and is one
of the most important enteric elminthic infections. In patients with
impaired cell mediated immunity, Strongyloides stercoralis may
disseminate to multiple organs and cause a life-threatening com-
plication called hyperinfection syndrome. Herein we present the
clinical course of an immunocompromised patient with Strongy-
loides hyperinfection syndrome.
Materials, Methods and Results: A 62 year old farmer was ad-
mitted to our department because of fever and severe headache
for the last 48 hours. He was on high dose of corticosteroids be-
cause of retroperitoneal fibrosis. On admission, he was lethar-
gic with nuchal rigidity. Cerebrospinal fluid (CSF) examination re-
vealed 4000 leukocytes/uL with neutrophil predominance (82%)
and CSF cultures grew Enterococcus feacalis. Blood and urine cul-
tures yielded no organism and the patient was treated with Ampi-
cilline and Gentamicin. Transesophageal echocardiogram and com-
puted tomography of abdomen and thorax, were negative. Two
days after initiation of treatment the patient was improved, but
on the 10th day he started vomiting. An upper endoscopy was per-
formed and jejunum biopsies revealed Strongyloides stercoralis.
On stool examination filariform larvae were seen. Bronchoalveolar
lavage as well as CSF sediment examination revealed filariform lar-
vae, so the diagnosis of hyperinfection syndrome was established.
The patient was treated with albendazole 400 mg BID, while corti-
costeroids were being tapered. Although the patient was on treat-
ment, the stool remained positive until the 10th week. The total
duration of treatment was 12 weeks. During a 4 months follow up,
no relapse was noted.
